Definitions of pan- and multidrug resistant (MDR) A. baumannii are not consistent in the literature ; typically MDR A. baumannii are resistant to aminoglycosides, antipseudomonal penicillins ...

The findings raised serious concerns. Seventy-five percent of the bacterial isolates showed some resistance to antibiotics, and over one-third qualified as multidrug-resistant. Many of these bacteria ...

Abstract. Amid the recent attention focused on the growing impact of methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa infections, the pathogen Acinetobacter ...

Investigation of the constituents of Pycnanthus angolensis roots has resulted in the isolation of four new cyclolignene derivatives, named pycnanthulignene A (1), pycnanthulignene B (2), ...

Since its initial description in the late 1930s, there have been many significant advances in the management of CF. Current standard of care includes regular chest physiotherapy, maximization of ...

Acinetobacter baumannii has been stealthily gaining ground as an agent of serious nosocomial and community-acquired infection; learn more about recent developments.

EAT based on an antipseudomonal β-lactam drug as monotherapy (ceftazidime or cefepime, meropenem or imipenem, or piperacillin-tazobactam) or as combination therapy (with an aminoglycoside, ...